Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, Michael A., Satpathy, Shankha, Cao, Song, Dhanasekaran, Saravana M., Vasaikar, Suhas V., Krug, Karsten, Petralia, Francesca, Li, Yize +178 more·2020·Cell

DOI 10.1016/j.cell.2020.06.013

Cited by (846)

Items 101–200 of 846

qPTM: an updated database for PTM dynamics in human, mouse, rat and yeast
Kai Yu, Ye Wang, Yongqiang Zheng, Zekun Liu, Qingfeng Zhang, Siyu Wang, Qi Zhao, Xiao-Long Zhang, Xiaoxing Li, Rui‐Hua Xu et al. · 2022 · Nucleic Acids Research
TIMP1 is an early biomarker for detection and prognosis of lung cancer
Ezequiel Dantas, Anirudh Murthy, Tanvir Ahmed, Mujmmail Ahmed, Shakti Ramsamooj, Maurice A. Hurd, Tiffany Lam, Murtaza S. Malbari, Christopher J. Agrusa, Olivier Elemento et al. · 2023 · Clinical and Translational Medicine
Prognostic and predictive biomarkers in non-small cell lung carcinoma
Igor Odintsov, Lynette Marie Sholl · 2023 · Pathology
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment
Kyu Jin Song, Seunghyuk Choi, Kwoneel Kim, Hee Sang Hwang, Eunhyong Chang, Ji Soo Park, Seok Bo Shim, Seunghwan Choi, Yong Jin Heo, Dae Yul Yang et al. · 2024 · Nature Communications
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma
Mircea Ştefan Tampa, Simona Roxana Georgescu, Mădălina Irina Mitran, Cristina Iulia Mitran, Clara Matei, Ana Căruntu, Cristian Scheau, Ilinca Nicolae, Andreea C. Matei, Constantin Căruntu et al. · 2021 · Biomolecules
Recent advances in mass-spectrometry based proteomics software, tools and databases
Ankit Halder, Ayushi Verma, Deeptarup Biswas, Sanjeeva Srivastava · 2021 · Drug Discovery Today Technologies
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
Michal Harel, Coren Lahav, Eyal Jacob, Nili Dahan, Itamar Sela, Yehonatan Elon, Shani Raveh, Galit Yahalom, Iris Kamer, Alona Zer et al. · 2022 · Journal for ImmunoTherapy of Cancer
Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics
Tian, Sha, Zhan, Dongdong, Yu, Ying, Wang, Yunzhi, Liu, Mingwei, Tan, Subei, Li, Yan, Song, Lei, Qin, Zhaoyu, Li, Xianju et al. · 2023 · Genome Biology
False discovery rate: the Achilles’ heel of proteogenomics
Suruchi Aggarwal, Anurag Raj, Dhirendra Kumar, Debasis Dash, Amit Kumar Yadav · 2022 · Briefings in Bioinformatics
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment
Shijie Tang, Yun Xue, Zhen Qin, Zhaoyuan Fang, Yihua Sun, Chongzhe Yuan, Yunjian Pan, Yue Zhao, Xinyuan Tong, Jian Zhang et al. · 2023 · National Science Review
Global impact of somatic structural variation on the cancer proteome
Fengju Chen, Yiqun Zhang, Darshan Shimoga Chandrashekar, Sooryanarayana Varambally, Chad J. Creighton · 2023 · Nature Communications
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images
Naofumi Tomita, Laura J. Tafe, Arief Antonius Suriawinata, Gregory J. Tsongalis, Mustafa Nasir-Moin, Konstantin H. Dragnev, Saeed Hassanpour · 2022 · Translational Oncology
PepQuery2 democratizes public MS proteomics data for rapid peptide searching
Bo Wen, Bing Zhang · 2023 · Nature Communications
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Joshua M. Wang, Runyu Hong, Elizabeth G. Demicco, Jimin Tan, Rossana Lazcano, Andre Luis Moreira, Yize Li, Anna Pamela Calinawan, Narges Razavian, Tobias Schraink et al. · 2023 · Cell Reports Medicine
Proteomics: An In‐Depth Review on Recent Technical Advances and Their Applications in Biomedicine
Jing Liang, Jun Tian, Huadong Zhang, Hua Li, Lixia Chen · 2025 · Medicinal Research Reviews
Co-occurring genomic alterations and immunotherapy efficacy in NSCLC
Fan Zhang, Jinliang Wang, Yu Xu, Shangli Cai, Tao Li, Guoqiang Wang, Chengcheng Li, Lei Zhao, Yi Hu · 2022 · npj Precision Oncology
Simplified and Unified Access to Cancer Proteogenomic Data
Caleb M. Lindgren, David W. Adams, Benjamin Kimball, Hannah Boekweg, Sadie Tayler, Samuel L. Pugh, Samuel Payne · 2021 · Journal of Proteome Research
Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers
Diana Monsivais, Yasmin M. Vasquez, Fengju Chen, Yiqun Zhang, Darshan Shimoga Chandrashekar, John C. Faver, Ramya P. Masand, Michael E. Scheurer, Sooryanarayana Varambally, Martin Matthew Matzuk et al. · 2021 · Oncogene
Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
Di Liu, Mengqiu Li, Zhiyao Zhao, Liang Zhou, Feng Zhi, Zhiyong Guo, Jun Cui · 2024 · Cancer Research
Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project
Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, Young‐Ki Paik, Ileana M. Cristea, Fernando José Corrales, Cecilia Lindskog, Susan T. Weintraub, Michael H. A. Roehrl, Siqi Liu et al. · 2021 · Journal of Proteome Research
Multi-omics characterization of autophagy-related molecular features for therapeutic targeting of autophagy
Mei Luo, Lin Ye, Ruimin Chang, Youqiong Ye, Zhao Zhang, Chunjie Liu, Shengli Li, Ying Jing, Hang Ruan, Guanxiong Zhang et al. · 2022 · Nature Communications
HER2 and HLA-A*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicity
David Bassan, Leehee Weinberger, Jason Yi, Tanya Kim, Michael R. Weist, Gregor B. Adams, Orit Foord, Neta Chaim, Sarit Tabak, Nir Bujanover et al. · 2023 · Journal for ImmunoTherapy of Cancer
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities
Whijae Roh, Yifat Geffen, Hongui Cha, Mendy L. Miller, Shankara K. Anand, Jaegil Kim, David I. Heiman, Justin F. Gainor, Peter W. Laird, Andrew D. Cherniack et al. · 2022 · Cancer Research
BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
Li, Kun, Liu, Yanan, Ding, Yi, Zhang, Zhengwei, Feng, Juanjuan, Hu, Jiaxin, Chen, Jiwei, Lian, Zhengke, Chen, Yiliang, Hu, Kewen et al. · 2022 · Journal of Clinical Investigation
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading
Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, Lars D. Engstrom, Jade Laguer, Andrew Calinisan, Allan Hebbert, Laura M. Waters, Krystal Moya, Vickie Bowcut et al. · 2024 · Molecular Cancer Therapeutics
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, Anna Dolnik, Matthias Ziehm, Oliver Popp, Eric Sträng, Miriam Kull, Florian Grünschläger, Josefine Krüger et al. · 2024 · Nature Cancer
Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy
Yuemin Wu, Wei Zhang, Xiao Liang, Pengpeng Zhang, Meng-Zhe Zhang, Yuqin Jiang, Yanan Cui, Yi Chen, Wenxin Zhou, Qi Liang et al. · 2025 · Journal of Translational Medicine
Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
Linyan Chen, Hao Zeng, Xiang Yu, Yeqian Huang, Yuling Luo, Xuelei Ma · 2021 · Frontiers in Cell and Developmental Biology
A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research
Efstathios–Iason Vlachavas, Jonas R. Bohn, Frank Ückert, Sylvia Nürnberg · 2021 · International Journal of Molecular Sciences
The Roles of RNA Helicases in DNA Damage Repair and Tumorigenesis Reveal Precision Therapeutic Strategies
Jinru Xie, Ming Wen, Jiao Zhang, Zheng Wang, Meng Wang, Yanfang Qiu, Wenchao Zhao, Fang Zhu, Mianfeng Yao, Zhuoxian Rong et al. · 2022 · Cancer Research
Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners
Himangi Srivastava, Michael J. Lippincott, Jordan Currie, Robert Canfield, Maggie P. Y. Lam, Edward Lau · 2022 · PLoS Computational Biology
A tissue-specific atlas of protein–protein associations enables prioritization of candidate disease genes
Diederik S. Laman Trip, Marc van Oostrum, Danish Memon, Fabian Frommelt, Delora Baptista, Kalpana Panneerselvam, Glyn Bradley, Luana Licata, Henning Hermjakob, Sandra E. Orchard et al. · 2025 · Nature Biotechnology
A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin-Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Genome biology
In-Depth Comparison of Matrigel Dissolving Methods on Proteomic Profiling of Organoids
Man Wang, Huan Yu, Ting Zhang, Lihua Cao, Yang Du, Yuhao Xie, Jiafu Ji, Jianmin Wu · 2021 · Molecular & Cellular Proteomics
Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
Yuna Guo, Wenshuang Jia, Jingru Yang, Xianquan Zhan · 2022 · Frontiers in Endocrinology
High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display
Allyson Li, Rashmi Voleti, Minhee Lee, Dejan Gagoski, Neel H. Shah · 2023 · eLife
Vacuolar proteomic analysis reveals tonoplast transporters for accumulation of citric acid and sugar in citrus fruit
Zuolin Mao, Yue Wang, Mengdi Li, Shuhang Zhang, Zeqi Zhao, Qiang Xu, Jihong Liu, Chunlong Li · 2023 · Horticulture Research
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun‐Yu Xu, Yuqi Huang, Jiacheng Guo, Qun Dong, Yanqing Wang, Ni Li, Qiuli Liu, Mingya Zhang, Qiang Pan‐Hammarström et al. · 2024 · Nature Cancer
Inflammatory reprogramming of the solid tumor microenvironment by infiltrating clonal hematopoiesis is associated with adverse outcomes
Marco M. Buttigieg, Caitlyn Vlasschaert, Alexander G. Bick, Robert J. Vanner, Michael J. Rauh · 2025 · Cell Reports Medicine
Quantitative proteomics characterization of cancer biomarkers and treatment
Xiao‐Li Yang, Yi Shi, Dandan Zhang, Rui Xin, Jing Deng, Ting‐Miao Wu, Huimin Wang, Pei‐Yao Wang, Jibin Liu, Wen Li et al. · 2021 · Molecular Therapy — Oncolytics
Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
Gina Bouchard, Fernando Jose Garcia-Marques, Loukia Georgiou Karacosta, Weiruo Zhang, Abel Bermudez, Nicholas McIlvain Riley, Sushama Varma, Lindsey Catherine Mehl, Jalen Anthony Benson, Joseph B. Shrager et al. · 2021 · Cancer Research
Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis
Yangmiao Duan, Jing Li, Fengqin Wang, Junmin Wei, Zhongfa Yang, Mingxin Sun, Jia Liu, Mingxin Wen, Wan Huang, Zhi‐Nan Chen et al. · 2021 · Cell Reports
Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses
Gali Arad, Tamar Geiger · 2023 · Molecular & Cellular Proteomics
Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium
Vincent Albrecht, Johannes Müller, Thierry M. Nordmann, Andreas Mund, Lisa Schweizer, Philipp Emanuel Geyer, Lili Niu, Juanjuan Wang, Frederik Post, Marc Oeller et al. · 2024 · Molecular & Cellular Proteomics
Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups
Shunrong Ji, Lihua Cao, Jing Gao, Yang Du, Ye Zeng, Xin Lou, Fen Liu, Yehan Zhang, Junfeng Xu, Xiaohan Shi et al. · 2025 · Cancer Cell
Comprehensive evaluation of phosphoproteomic-based kinase activity inference
Sophia Müller‐Dott, Eric J. Jaehnig, Khoi Pham Munchic, Wen Jiang, Tomer M. Yaron, Sara R. Savage, Martín Garrido‐Rodríguez, Jared Lee Johnson, Alessandro Lussana, Evangelia Petsalaki et al. · 2025 · Nature Communications
Reflections on the HUPO Human Proteome Project, the Flagship Project of the Human Proteome Organization, at 10 Years
Gilbert S. Omenn · 2021 · Molecular & Cellular Proteomics
Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer
Jason Hongting Leung, Benjamin Ng, Wei‐Wen Lim · 2022 · Cells
Label-free proteome quantification and evaluation
Jianbo Fu, Qingxia Yang, Yongchao Luo, Song Zhang, Jing Tang, Ying Zhang, Hongning Zhang, Hanxiang Xu, Feng Zhu · 2022 · Briefings in Bioinformatics
HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
Jie Wang, Feng Yun, Jiahui Sui, Wenpeng Liang, Dingding Shen, Qi Zhang · 2022 · Biomedicines
Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids through Functionally Tunable Paramagnetic Separation
Jie Sun, Qing X. Li, Yajie Ding, Dong Wei, Marco Hadisurya, Zhuojun Luo, Zhongze Gu, Bobin Chen, W. Andy Tao · 2023 · Angewandte Chemie International Edition
A partial epithelial‐mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction
Gil A Pastorino, Ilir Sheraj, K Huebner, Giulio Ferrero, Philipp Kunze, Arndt Hartmann, Chuanpit Hampel, Hepşen Hazal Hüsnügil, Arnatchai Maiuthed, Florian Gebhart et al. · 2024 · The Journal of Pathology
GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma
Wei Wang, Ruiying Sun, Lizhong Zeng, Yang Chen, Na Zhang, Shiguang Cao, Shanshan Deng, Meng Xia, Shuanying Yang · 2021 · Life Sciences
Mass Spectrometry–Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine
Sunil Kumar Joshi, Paul Piehowski, Tao Liu, Sara J.C. Gosline, Jason McDermott, Brian J. Druker, Elie A. Traer, Jeffrey W Tyner, Anupriya Agarwal, Cristina E. Tognon et al. · 2023 · The Annual Review of Pharmacology and Toxicology
p53 mutation and deletion contribute to tumor immune evasion
Si‐Yang Maggie Liu, Tianyao Liu, Jiaxuan Jiang, Hongqian Guo, Rong Li Yang · 2023 · Frontiers in Genetics
Metabolic reprogramming of neutrophils in the tumor microenvironment: Emerging therapeutic targets
Shiyun Huang, Jiahao Shi, Jianfeng Shen, Xianqun Fan · 2025 · Cancer Letters
In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer
Beáta Szeitz, Zsolt Megyesfalvi, Nicole Woldmar, Zsuzsanna Valkó, Anna Solta, Nándor Bárány, Sándor Paku, Viktória László, Helga Kiss, Edina Bugyik et al. · 2022 · Clinical and Translational Medicine
MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation
Yuan Wang, Zhenchang Jia, Chenxi Liang, Yunfei He, Min Cong, Qiuyao Wu, Pu Tian, Dasa He, Xiang Miao, Beibei Sun et al. · 2023 · Cell Discovery
Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC
Shasha Wang, Guangyu Fan, Lin Li, Yajun He, Ning Lou, Tongji Xie, Liyuan Dai, Ruyun Gao, Mengwei Yang, Yuankai Shi et al. · 2023 · Cancer Immunology Immunotherapy
The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
Shiyan Wang, Yong Zeng, Lin Zhu, Min Zhang, Lei Zhou, Weixiong Yang, Weishan Luo, Lina Wang, Yanming Liu, Helen Zhu et al. · 2024 · Cancer Discovery
Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications
Sander R. Piersma, Andrea Vallés‐Martí, Frank Rolfs, Thang V. Pham, Alex A. Henneman, Connie R. Jiménez · 2022 · Mass Spectrometry Reviews
Pan‐Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival
Abel Sousa, Aurélien J. F. Dugourd, Danish Memon, Borgþór Pétursson, Evangelia Petsalaki, Julio Sáez-Rodríguez, Pedro Beltrão · 2023 · Molecular Systems Biology
Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma
Yang Zhang, Fangqiu Fu, Qiao Zhang, Lingling Li, Hui Liu, Chaoqiang Deng, Qianqian Xue, Yue Zhao, Wenrui Sun, Han Han et al. · 2024 · Cell Reports Medicine
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
James C. Pino, Camilo Posso, Sunil Kumar Joshi, Michael D. Nestor, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch, Marina Gritsenko, Karl Weitz, Kevin Watanabe‐Smith et al. · 2024 · Cell Reports Medicine
IL‐36γ and IL‐36Ra Reciprocally Regulate NSCLC Progression by Modulating GSH Homeostasis and Oxidative Stress‐Induced Cell Death
Peng Wang, Wei Zhong Yang, Hao Guo, Hong‐Peng Dong, Yu‐Yao Guo, Hu Gan, Zou Wang, Yongbo Cheng, Yu Deng, Shi-Zhe Xie et al. · 2021 · Advanced Science
Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways
2022
Clinical proteomics towards multiomics in cancer
Chad J. Creighton · 2022 · Mass Spectrometry Reviews
Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Fenghui Zhuang, E Haoran, Jia Huang, Junqi Wu, Long Xu, Lei Zhang, Qiang Li, Chongwu Li, Yue Zhao, Minglei Yang et al. · 2023 · Lung Cancer
Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing
Zhifei Ma, Hao Chen, Zhijun Xia, Jing You, Chencheng Han, Siwei Wang, Wenjia Xia, Yongkang Bai, Tongyan Liu, Lin Xu et al. · 2023 · Journal of Experimental & Clinical Cancer Research
Tumors Widely Express Hundreds of Embryonic Germline Genes
Jan Willem Bruggeman, Naoko Irie, Paul Lodder, Ans M. M. van Pelt, Jan Köster, Geert Hamer · 2020 · Cancers
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Uliana J. Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey et al. · 2021 · Frontiers in Immunology
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges
Alberto Servetto, Daniela Esposito, Roberto Ferrara, Diego Signorelli, Stefania Belli, Fabiana Napolitano, Antonio Santaniello, Paola Ciciola, Luigi Formisano, Roberto Bianco · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer
Runhao Xu, Jiongran Wang, Qingqing Zhu, Chen Zou, Zehao Wei, Hao Wang, Zian Ding, Minjie Meng, Huimin Wei, Shijin Xia et al. · 2023 · Biomarker Research
Alternate RNA decoding results in stable and abundant proteins in mammals
Shira Tsour, Rainer Machné, Andrew Leduc, Simon D. Widmer, Eunice Koo, Jérémy Guez, Konrad J. Karczewski, Nikolai Slavov · 2026 · Nature
YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway
Teng Zhao, Mingchao Wang, Xin Zhao, Shuang Weng, Kun Qian, Kejian Shi, Yanfei Gu, Wantao Ying, Xiaohong Qian, Yi Zhang · 2022 · Frontiers in Oncology
Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma
Quanyou Wu, Lin Feng, Yaru Wang, Yousheng Mao, Xuebing Di, Kaitai Zhang, Shujun Cheng, Ting Xiao · 2022 · Signal Transduction and Targeted Therapy
Foresight in clinical proteomics: current status, ethical considerations, and future perspectives
Filip Mundt, Nicolai J. Wewer Albrechtsen, Sebastian Porsdam Mann, Peter V. Treit, Medini Ghodgaonkar-Steger, Martina C. O’Flaherty, Reinout Raijmakers, Juan Antonio Vizcaíno, Albert J. R. Heck, Matthias Mann · 2023 · Open Research Europe
An antioxidant feedforward cycle coordinated by linker histone variant H1.2 and NRF2 that drives nonsmall cell lung cancer progression
Yuchen Chen, Jiajian Shi, Xiaomu Wang, Lin Zhou, Qing Wang, Yunhao Xie, Chentai Peng, Linwu Kuang, Dong Liang Yang, Jing Yang et al. · 2023 · Proceedings of the National Academy of Sciences
LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy
Liang Wang, Jieyi Fan, Sifan Wu, Shilin Cheng, Junlong Zhao, Fan Fan, Chun-Chen Gao, Rong Qiao, Qiqi Sheng, Yiyang Hu et al. · 2024 · iMeta
Magneto: Combining Small and Large Language Models for Schema Matching
Yurong Liu, Eduardo H. M. Pena, Aécio S. R. Santos, Eden Wu, Juliana Freire · 2025 · Proceedings of the VLDB Endowment
α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer
Chia-Hao Tung, Meng‐Fan Huang, Chen-Hsien Liang, Yi-Ying Wu, Jiaen Wu, Cheng–Lung Hsu, Yuh‐Ling Chen, Tse-Ming Hong · 2022 · Theranostics
Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
Kenny Kwok Hei Yu, Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer K. Gantchev, Sonali Jindal, Michael Scott Regan, Zaki Abou-Mrad, Michael C. Prabhu, Marc J. Williams et al. · 2025 · Nature Communications
Protein-based classification reveals an immune-hot subtype in IDH mutant astrocytoma with worse prognosis
Jihong Tang, Wenhua Fan, Yuyan Ruan, Xing Liu, Fufang Qiu, Jie Feng, Guoshi Huang, Mengli Yan, Hui Wang, Quanhua Mu et al. · 2025 · Cancer Cell
A comprehensive map of alternative polyadenylation in African American and European American lung cancer patients
A. Zingone, Sanju Sinha, M. Ante, Cu Nguyen, D. Daujotytė, E. Bowman, Neelam Sinha, Khadijah A. Mitchell, Qing-Rong Chen, Chun-Hua Yan et al. · 2021 · Nature Communications
Deciphering the tumor microenvironment cell–infiltrating landscape reveals microenvironment subtypes and therapeutic potentials for nonsquamous NSCLC
Hao Chen, Tongchao Zhang, Yuan Zhang, Hao Wu, Zhen Fang, Yang Liu, Yang Chen, Zhe Wang, Shengtao Jia, Xingzhao Ji et al. · 2022 · JCI Insight
Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
Ivan Cohen, Fresia G. Pareja, Nicholas D. Socci, Ronglai Shen, Ashley S. Doane, Jazmin Schwartz, Raya Khanin, Elizabeth Ann Morris, Elizabeth Jane Sutton, Ronald G. Blasberg · 2022 · Frontiers in Immunology
Omics-based molecular classifications empowering in precision oncology
Zhaokai Zhou, Ting Lin, Shuang Chen, Ge Zhang, Yudi Xu, Haijiao Zou, Aoyang Zhou, Yuyuan Zhang, Siyuan Weng, Xinwei Han et al. · 2024 · Cellular Oncology
PCAS: An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data
Jin Wang, Xiangrong Song, Meidan Wei, Lexin Qin, Qingyun Zhu, Shujie Wang, Tingting Liang, Wentao Hu, Xinyu Zhu, Jianxiang Li · 2024 · International Journal of Molecular Sciences
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma
Jun Jiang, Chao Xu, Donghui Han, Yuan Lu, Fa Yang, Jiawei Wang, Xiaolong Yan, Xiaorong Mu, Jipeng Zhang, Chenghui Jia et al. · 2024 · Biomarker Research
MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma
Yan Chen, Xinsheng Zhu, Jue Wang, Junjie Hu, Jing Zhang, Xun Zhang, Lu Han, Huansha Yu, Hai Hu, Ke Fei et al. · 2024 · Oncogene
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy
Giulia Mazzaschi, Alessandro Leonetti, Roberta Minari, Letizia Gnetti, Federico Quaini, Marcello Tiseo, Francesco Facchinetti · 2021 · Current Treatment Options in Oncology
Prediction of Lung Cancer using Convolution Neural Networks
Aanchal Vij, Kuldeep Singh Kaswan · 2023 · International Conference on Artificial Intelligence and Smart Communication (AISC)
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
Jun Li, Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju, Shwetha V. Kumar, Patrick Kwok‐Shing Ng, Han Chen, Michael A. Davies et al. · 2024 · Nature Cancer
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers
Guo-Sheng Hu, Zao-zao Zheng, Yao-Hui He, Du-chuang Wang, Rui Nie, Wen Liu · 2025 · Molecular & Cellular Proteomics
Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma
John L. Pulice, Matthew M. Meyerson · 2023 · Molecular Cell
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
Céline Mascaux, Triparna Sen, Montse Sánchez‐Céspedes, Sandra Ortiz‐Cuaran, Yohan Bossé, Floris F. Dammeijer, Milena R. Cavic, Martin P. Barr, Surein Arulananda, Ricardo Armisén et al. · 2025 · Journal of Thoracic Oncology
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Shankha Satpathy, Natalie M. Clark, Yi‐Ju Chen, Noshad Hosseini, Ya-Hsuan Chang, Yi Hsiao, Jonathan Thomas Lei, Francesca Petralia, Jin‐Shing Chen, Yifat Geffen et al. · 2025 · Cancer Cell
Deep computational analysis details dysregulation of eukaryotic translation initiation complex eIF4F in human cancers
Wu, Su, Wagner, Gerhard · 2021 · Cell Systems
Comparative profiling of single-cell transcriptome reveals heterogeneity of tumor microenvironment between solid and acinar lung adenocarcinoma
Dianke Li, Huansha Yu, Junjie Hu, Shaoling Li, Yilv Yan, Shuangyi Li, Liangdong Sun, Gening Jiang, Likun Hou, Lele Zhang et al. · 2022 · Journal of Translational Medicine
The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma
Rui Yang, Weilin Peng, Shuai Shi, Xiong Peng, Qidong Cai, Zhenyu Zhao, Boxue He, Guangxu Tu, Wei Yin, Yichuan Chen et al. · 2023 · Advanced Science